These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31013940)

  • 1. Mining for Oxysterols in
    Meljon A; Crick PJ; Yutuc E; Yau JL; Seckl JR; Theofilopoulos S; Arenas E; Wang Y; Griffiths WJ
    Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.
    Schöls L; Rattay TW; Martus P; Meisner C; Baets J; Fischer I; Jägle C; Fraidakis MJ; Martinuzzi A; Saute JA; Scarlato M; Antenora A; Stendel C; Höflinger P; Lourenco CM; Abreu L; Smets K; Paucar M; Deconinck T; Bis DM; Wiethoff S; Bauer P; Arnoldi A; Marques W; Jardim LB; Hauser S; Criscuolo C; Filla A; Züchner S; Bassi MT; Klopstock T; De Jonghe P; Björkhem I; Schüle R
    Brain; 2017 Dec; 140(12):3112-3127. PubMed ID: 29126212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.
    Marelli C; Lamari F; Rainteau D; Lafourcade A; Banneau G; Humbert L; Monin ML; Petit E; Debs R; Castelnovo G; Ollagnon E; Lavie J; Pilliod J; Coupry I; Babin PJ; Guissart C; Benyounes I; Ullmann U; Lesca G; Thauvin-Robinet C; Labauge P; Odent S; Ewenczyk C; Wolf C; Stevanin G; Hajage D; Durr A; Goizet C; Mochel F
    Brain; 2018 Jan; 141(1):72-84. PubMed ID: 29228183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment.
    Mignarri A; Carecchio M; Del Puppo M; Magistrelli L; Di Bella D; Monti L; Dotti MT
    J Neurol Sci; 2017 Dec; 383():39-41. PubMed ID: 29246618
    [No Abstract]   [Full Text] [Related]  

  • 5. SPG5 and multiple sclerosis: clinical and genetic overlap?
    Criscuolo C; Carbone R; Lieto M; Peluso S; Guacci A; Filla A; Quarantelli M; Lanzillo R; Morra VB; De Michele G
    Acta Neurol Scand; 2016 Jun; 133(6):410-4. PubMed ID: 26370385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24S,25-Epoxycholesterol in mouse and rat brain.
    Wang Y; Karu K; Meljon A; Turton J; Yau JL; Seckl JR; Wang Y; Griffiths WJ
    Biochem Biophys Res Commun; 2014 Jun; 449(2):229-34. PubMed ID: 24832732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome Sequencing Reveals a Novel Homozygous Frameshift Mutation in the CYP7B1 Gene in a Japanese Patient with SPG5.
    Nan H; Shimozono K; Ichinose Y; Tsuchiya M; Koh K; Hiraide M; Takiyama Y
    Intern Med; 2019 Mar; 58(5):719-722. PubMed ID: 30333426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.
    Schüle R; Siddique T; Deng HX; Yang Y; Donkervoort S; Hansson M; Madrid RE; Siddique N; Schöls L; Björkhem I
    J Lipid Res; 2010 Apr; 51(4):819-23. PubMed ID: 19812052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative modeling of 25-hydroxycholesterol-7α-hydroxylase (CYP7B1): ligand binding and analysis of hereditary spastic paraplegia type 5 CYP7B1 mutations.
    Siam A; Brancale A; Simons C
    J Mol Model; 2012 Feb; 18(2):441-53. PubMed ID: 21541746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the regulatory importance of 27-hydroxycholesterol in mouse liver.
    Heverin M; Ali Z; Olin M; Tillander V; Joibari MM; Makoveichuk E; Leitersdorf E; Warner M; Olivercrona G; Gustafsson JÅ; Björkhem I
    J Steroid Biochem Mol Biol; 2017 May; 169():10-21. PubMed ID: 26851362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5.
    Goizet C; Boukhris A; Durr A; Beetz C; Truchetto J; Tesson C; Tsaousidou M; Forlani S; Guyant-Maréchal L; Fontaine B; Guimarães J; Isidor B; Chazouillères O; Wendum D; Grid D; Chevy F; Chinnery PF; Coutinho P; Azulay JP; Feki I; Mochel F; Wolf C; Mhiri C; Crosby A; Brice A; Stevanin G
    Brain; 2009 Jun; 132(Pt 6):1589-600. PubMed ID: 19439420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis.
    Raselli T; Hearn T; Wyss A; Atrott K; Peter A; Frey-Wagner I; Spalinger MR; Maggio EM; Sailer AW; Schmitt J; Schreiner P; Moncsek A; Mertens J; Scharl M; Griffiths WJ; Bueter M; Geier A; Rogler G; Wang Y; Misselwitz B
    J Lipid Res; 2019 Jul; 60(7):1270-1283. PubMed ID: 31113816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse.
    Meljon A; Wang Y; Griffiths WJ
    Biochem Biophys Res Commun; 2014 Apr; 446(3):768-74. PubMed ID: 24491562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated hydroxycholesterols in Norwegian patients with hereditary spastic paraplegia SPG5.
    Prestsæter S; Koht J; Lamari F; Tallaksen CME; Hoven STJ; Vigeland MD; Selmer KK; Rydning SL
    J Neurol Sci; 2020 Dec; 419():117211. PubMed ID: 33160247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of Taiwanese patients with Hereditary spastic paraplegia type 5.
    Chou CT; Soong BW; Lin KP; Tsai YS; Jih KY; Liao YC; Lee YC
    Ann Clin Transl Neurol; 2020 Apr; 7(4):486-496. PubMed ID: 32202070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1-/- mouse brain and plasma.
    Griffiths WJ; Crick PJ; Meljon A; Theofilopoulos S; Abdel-Khalik J; Yutuc E; Parker JE; Kelly DE; Kelly SL; Arenas E; Wang Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Feb; 1864(2):191-211. PubMed ID: 30471425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
    Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
    Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
    Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations.
    Arnoldi A; Crimella C; Tenderini E; Martinuzzi A; D'Angelo MG; Musumeci O; Toscano A; Scarlato M; Fantin M; Bresolin N; Bassi MT
    Clin Genet; 2012 Feb; 81(2):150-7. PubMed ID: 21214876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary spastic paraparesis due to SPG5/CYP7B1 mutation with potential therapeutic implications.
    Pérez-Torre P; García Galloway E; López-Sendón Moreno JL
    Neurologia (Engl Ed); 2023; 38(9):710-711. PubMed ID: 37858890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.